Selloff defies logic and cannot last, page-2

First 2 Last

Share
Profile

Follow
AshleySix

540 Posts.

07/03/17

19:21

Post #: 23165963
Share

Originally posted by asx_dude ↑

Lets look at the solid positive LT fundamentals here:
IO around 90 per tonne and still on LT trend in bull market.
AGOs on target to annihilate debt soon after this quarter, with cash to fund C.Downs.
JV potential.
Lithium potential.
Chinas demand strong as it pushes with urbanisation and mammoth infrastructure projects as it continues to deal with its domestic supply of uneconomical tonnes.
US sticking to the plan to rebuild a better America.
South East Asia growth bordering China is ramping up.
India ramping up urbanisation as China (Mach 2).
Global demand on the up.
Majors supply peaking.

Oversold territory and completely illogical in my eyes if the SP was to fall further ST-MT. Congratulations to accumulators of AGO.
Let's assume debt holders have dumped the last of their shares there's no way to go for shorts.
Downside is completely exhausted and the lingering doomy forecasts which since April last year, have been playing catchup to save face, it's time to pass the wooden spoon award to the experts who claimed AGOs death and IO would fall back to a level which made no economical sense globally. It's time shorts packed up and left commodities as it will be tough going from here on in. Good luck debt holders. Good luck holders as this AGO train is only just beginning to gain steam.

Expand

99% of what you say is correct and i agree with you. BUT have the debt holder's finished, i still think they have about half done and not more.

If anyone on here has better numbers on how much more debt holders have to go would love to see it please.

Ashley

AGO Price at posting: 3.2¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 59 more messages in this thread...

First 2 Last

Add AGO (ASX) to my watchlist

Selloff defies logic and cannot last, page-2

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News